emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

CooperSurgical / Research Instruments

No EMAT : 78139
Announced Date : 17/12/2015
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : CooperSurgical

Target : Research Instruments
Country : United Kingdom
Sector of activity :
  • Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Equipment
Business Description :
Founded in 1962, Research Instruments s pecialises in cutting-edge technology, consumables and hardware in the field of in-vitro fertilisation (IVF) used in micromanipulation technology. > Line of...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Equipment » = 231
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
28/01/2016 Enzymatica Zymetech ehf Iceland *** 78061
02/07/2014 Klinik Hirslanden Swissana Clinic Meggen Switzerland *** 78037

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report